Universe Pharmaceuticals INC
UPC
$5.94
-$1.15-16.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -777.40K | -777.40K | -193.70K | -193.70K | -1.64M |
| Total Depreciation and Amortization | 115.60K | 115.60K | 123.90K | 123.90K | 134.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 185.30K | 185.30K | -- |
| Change in Net Operating Assets | -1.49M | -1.49M | -3.92M | -3.92M | 2.79M |
| Cash from Operations | -2.15M | -2.15M | -3.81M | -3.81M | 1.28M |
| Capital Expenditure | -155.50K | -155.50K | -85.00K | -85.00K | -48.40K |
| Sale of Property, Plant, and Equipment | -- | -- | 2.70K | 2.70K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -750.80K | -750.80K | -22.20K | -22.20K | -18.00K |
| Cash from Investing | -906.30K | -906.30K | -104.50K | -104.50K | -66.40K |
| Total Debt Issued | 1.78M | 1.78M | 4.09M | 4.09M | 1.04M |
| Total Debt Repaid | -1.86M | -1.86M | -7.43M | -7.43M | -345.70K |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 7.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -74.50K | -74.50K | -3.34M | -3.34M | 8.20M |
| Foreign Exchange rate Adjustments | 113.80K | 113.80K | 407.00K | 407.00K | -525.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.02M | -3.02M | -6.84M | -6.84M | 8.89M |